美国银行降低了精确科学的价格目标, 但分析师保持“机动购买”立场。 Bank of America lowers Exact Sciences' price target, but analysts maintain a "Moderate Buy" stance.

美国银行将其精密科学(NASDAQ:EXAS)的价格目标降低到65美元,表明可能比当前股价上涨28.76%。 Bank of America lowered its price target for Exact Sciences (NASDAQ: EXAS) to $65, indicating a potential 28.76% rise from the current stock price. 尽管如此,分析师还是有一个“机动购买”共识,平均目标价格为72.06美元。 Despite this, analysts have a "Moderate Buy" consensus with an average target price of $72.06. 精确科学组织最近报告,Q1 EPS为(0.06美元),使分析师的估计数比0.23美元有所改善。 Exact Sciences recently reported a Q1 EPS of ($0.06), bettering analyst estimates by $0.23. 机构投资者拥有公司相当可观的88.82%的股票。 Institutional investors hold a significant 88.82% of the company's stock.